Skip to main content
AT

Arcade Therapeutics

Arcade Therapeutics develops mobile games that utilize neurocognitive training techniques to provide non-prescription treatments for anxiety disorders, specifically targeting social anxiety disorder in adolescents and adults. Their flagship product, StarStarter, has demonstrated measurable reductions in anxiety symptoms and is designed for integration into healthcare workflows for seamless provider-patient interaction.

Montclair, United StatesFounded 2019111K+ followers
Updated 4 months ago

Funding

$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Individuals experiencing anxiety disorders, particularly social anxiety, often face barriers to accessing traditional mental health treatments due to factors such as cost, stigma, and limited availability of specialists. Existing therapeutic options may not be engaging or easily integrated into daily life, leading to poor adherence and suboptimal outcomes.

Solution

Arcade Therapeutics develops mobile games utilizing neurocognitive training techniques to provide accessible and engaging non-prescription treatments for anxiety disorders. Their flagship product, StarStarter Rx (ABM-01), is designed as a digital therapeutic intervention for social anxiety disorder, delivering clinically validated cognitive exercises through casual mobile gameplay. The platform aims to improve mental health outcomes by offering a convenient, discreet, and gamified approach to anxiety management, potentially enhancing patient adherence and reducing barriers to care. By translating breakthrough neuroscience into accessible digital therapies, Arcade Therapeutics seeks to transform mental health treatment delivery and improve overall well-being.

Target Audience

The primary target audience includes adolescents and adults experiencing social anxiety disorder, as well as healthcare providers seeking innovative, non-prescription treatment options to integrate into their practice.

Features

  • Mobile game-based neurocognitive training for anxiety reduction
  • Clinically validated exercises embedded within engaging gameplay
  • Designed for integration into healthcare workflows
  • Aims to reduce self-reported anxiety and stress hormone cortisol
  • Gamified approach to improve patient engagement and adherence
  • Potential for prescription as a digital therapeutic (PDT)
  • Pipeline includes products targeting adult SAD, adult GAD, adult MDD, pediatric GAD and SAD, alcohol use disorder, chronic pain-related anxiety and perinatal anxiety
This profile is AI-generated and may contain inaccuracies.